Their single center, randomized, double-blind, placebo-controlled, single ascending dose study showed significant within-group improvement in pain scores from baseline at all-time points for the PRG group, with highly significant improvements seen at months 3, 6, 9, and 12 compared to the marginal improvement in the placebo group [ 102 ].
← all excerpts
Therapeutic Potential of Adipose Mesenchymal Stem Cells for Synovial Regeneration: from In-Vitro Studies to Clinical Applications.
1
—
—